Total dose infusion of fractionated iron dextran complex in management of anaemia in antenatal cases

Authors

  • Manjunath S Assistant Professor, Department of Obstetrics & Gynecology, Hassan Institute of Medical Science, Hassan, Karnataka, India
  • Veena H C Post Graduate, Department of Physiology, Navodaya Medical College, Raichur, Karnataka, India

Keywords:

Iron deficiency anemia, Pregnancy, Hemoglobin, Low molecular weight fractionated iron dextran, Total dose Infusion

Abstract

Background: Iron deficiency anemia is common clinical manifestation in pregnancy. It can be easily prevented or corrected by early diagnosis and proper treatment successfully. This study was done to know the efficacy, effectiveness, rise in hemoglobin level and adverse effects of newly available low molecular weight iron dextran complex.

Methods: A prospective clinical trial was conducted in randomly selected 50 antenatal women who attended the OPD of OBG department and were moderately anemic and fulfilled the inclusion criteria of the study

Results: All the 50 women were moderately anemic with hemoglobin level between 7-9 gm%. After total dose infusion of low molecular weight fractionated iron dextran complex, hemoglobin level was measured at 4 weeks and at term. The mean hemoglobin level rose to 9.5 gm/dl by 4 weeks after infusion and to 11.53 gm/dl at term, which was statistically significant (p<0.0001). Only one patient developed non-cardiac chest pain during the test dose and two patients developed urticaria during total dose infusion.

Conclusion: The study showed a statistically significant increase in hemoglobin level after total dose infusion of low molecular weight iron dextran complex with a good safety profile and minimal hospital stay.

References

Usha Krishna et al., Anemia in Pregnancy: Pregnancy at risk current concepts: The Federation of obstetrics and Gynecological Society of India: Chapter 40: 4th Edition 2001: pp: 229-332.

Toteja G.S., Padam Singh. Iron deficiency anaemia: Micronutrient Profile of Indian Population: Indian Council of Medical Research: New Delhi - 2004: pp: 556.

Toteja G.S., Padam Singh. Pregnant and lactating women current status: Iron deficiency anaemia: Micronutrient Profile of Indian Population Chapter 4.1.3: Indian Council of Medical Research: New Delhi -2004: pp 32-34.

Jai B Sharma et al.: A prospective randomized study of pregnancy outcomes and hematolOgical responses to Iron treatment in moderately anaemic pregnant women: AM J Nutr 2004: 70: pp: 116 -22.

John Studd. Iron deficiency Anaemia: Nutritional anaemia during pregnancy is non- industrialized countries: progress in obstetrics and gynecology Chapter 7: Vol.15.2003:pp:107-110.

Sharma J.B., Soni D., Oxidative stress in pregnancy - Role of iron therapy: oral iron therapy and risk of free radicals: Obs and Gynac: vol. VI No.12: Dec. 2001: pp 705-706.

Richard A. et al., Parenteral iron formulation: A comparative toxicological analyses and mechanism of cell injury: American Journal of Kidney diseases: Vol. 40: No.1 July 2002: pp: 90-103.

Hallak M et al.: Supplementing iron intravenously in pregnancy: A way to avoid blood transfusion: Feb. 1997 42(2): pp: 99-103.

Fleter R., Lazarus JM, Gage J., Chertow G.M.: Suspected iron dextran -related adverse drug events in Hemodialysis patient: AM J Kidney Dis 37 (4) 2001: 743 - 749.

Ahlmen J., Vaage - Nilnen O: Safety evaluation of iron (Ferriecit ®, DexferrUm ®, Infed ®) from 21,060,000 Doses Administered 1.V in the US 1990-2000: Nephrol Dial Transplant 17 (Suppler) 2002: 133, #M305.

Zager R.A., Johnson A.C.M., Hanson S.Y., Wasseh H. Parenteral Iron Formulations: A Comparative Toxicological Analysis and Mechanisms of Cell Injury. AM J Kidney Dis 2002;40(1):90-103.

Downloads

Published

2016-12-10

Issue

Section

Original Research Articles